BioCentury
ARTICLE | Clinical News

APX001 regulatory update

June 20, 2016 7:00 AM UTC

Amplyx Pharmaceuticals Inc., San Diego, Calif. Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Product: APX001 Business: Infectious FDA granted Qualified Infectious Disease Product (QIDP) designation to AP...